W. Vickery Stoughton
Chief Executive Officer at Santa Clara Aquamaids
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey T. Lum | M | 77 |
Santa Clara Aquamaids
| - |
| Natalie Brady | F | - | 24 years | |
| Dawn Lai | F | - | 26 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Edward A. Taylor | M | 81 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 13 years |
| Dean Connor | M | 67 | 15 years | |
| Christopher Henney | M | 83 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 13 years |
| Robert L. Kirkman | M | 75 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 10 years |
| Richard L. Jackson | M | 84 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 14 years |
| Don Stewart | M | 77 | 12 years | |
| Colm Freyne | M | 65 | 19 years | |
| S. Robert Blair | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 15 years |
| John Henry Clappison | M | 77 | 11 years | |
| Idie Kesner | M | 66 | 12 years | |
| T. Alex McPherson | M | 85 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 15 years |
| Steven James | M | 66 | 3 years | |
| Shashi Karan | M | 70 | 2 years | |
| Gary W. Christianson | M | 69 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 11 years |
| Douglas Williams | M | 66 | 4 years | |
| Mitchell M. Merin | M | 71 | 6 years | |
| Tony Brenner | M | 66 |
Careside, Inc.
 Careside, Inc. Medical SpecialtiesHealth Technology Careside, Inc. develops and sells a proprietary blood testing systems. The Careside system consists of the Careside Analyzer and disposable test cartridges, the H-2000 and Careside connect. The Careside Analyzer is easy to use and can be operated by a non-technical person with appropriate training in connection with use of the device. Its software will enable the user to capture all data required to comply with the clinical laboratory improvement. The company was founded in July 1996 and is headquartered in Culver City, CA. | - |
| Krystyna Hoeg | F | 74 | 14 years | |
| Mary de Paoli | F | - | - | |
| Michael J. O'Connor | M | 55 | - | |
| R. Rao Koganty | M | 81 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 22 years |
| Paul Petrelli | M | - | 20 years | |
| Diana Hausman | M | 61 | 7 years | |
| William F. Flatley | M | 82 |
Careside, Inc.
Careside, Inc. Medical SpecialtiesHealth Technology Careside, Inc. develops and sells a proprietary blood testing systems. The Careside system consists of the Careside Analyzer and disposable test cartridges, the H-2000 and Careside connect. The Careside Analyzer is easy to use and can be operated by a non-technical person with appropriate training in connection with use of the device. Its software will enable the user to capture all data required to comply with the clinical laboratory improvement. The company was founded in July 1996 and is headquartered in Culver City, CA. | - |
| C. Alan MacDonald | M | 90 |
Careside, Inc.
Careside, Inc. Medical SpecialtiesHealth Technology Careside, Inc. develops and sells a proprietary blood testing systems. The Careside system consists of the Careside Analyzer and disposable test cartridges, the H-2000 and Careside connect. The Careside Analyzer is easy to use and can be operated by a non-technical person with appropriate training in connection with use of the device. Its software will enable the user to capture all data required to comply with the clinical laboratory improvement. The company was founded in July 1996 and is headquartered in Culver City, CA. | - |
| Diana J. Mackie | F | 76 |
Careside, Inc.
Careside, Inc. Medical SpecialtiesHealth Technology Careside, Inc. develops and sells a proprietary blood testing systems. The Careside system consists of the Careside Analyzer and disposable test cartridges, the H-2000 and Careside connect. The Careside Analyzer is easy to use and can be operated by a non-technical person with appropriate training in connection with use of the device. Its software will enable the user to capture all data required to comply with the clinical laboratory improvement. The company was founded in July 1996 and is headquartered in Culver City, CA. | - |
| Michael C. Welsh | M | 81 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 21 years |
| Julia Eastland | F | 59 | 8 years | |
| C. Prieur | M | 72 | 27 years | |
| Ken Kermes | M | 88 |
Careside, Inc.
Careside, Inc. Medical SpecialtiesHealth Technology Careside, Inc. develops and sells a proprietary blood testing systems. The Careside system consists of the Careside Analyzer and disposable test cartridges, the H-2000 and Careside connect. The Careside Analyzer is easy to use and can be operated by a non-technical person with appropriate training in connection with use of the device. Its software will enable the user to capture all data required to comply with the clinical laboratory improvement. The company was founded in July 1996 and is headquartered in Culver City, CA. | - |
| D. Kirkpatrick | M | 67 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 2 years |
| David A. Ganong | M | 80 | - | |
| David Kerr | M | 80 | 9 years | |
| Dan Spiegelman | M | 65 | 10 years | |
| Ted Love | M | 65 | 5 years | |
| Ronald Walter Osborne | M | 77 | 12 years | |
| Scott Robert Peterson | M | 62 | 9 years | |
| Drew J. Niziak | M | - | - | |
| Matt Ritzel | M | - | 4 years | |
| Thomas H. Grove | M | 74 |
Careside, Inc.
Careside, Inc. Medical SpecialtiesHealth Technology Careside, Inc. develops and sells a proprietary blood testing systems. The Careside system consists of the Careside Analyzer and disposable test cartridges, the H-2000 and Careside connect. The Careside Analyzer is easy to use and can be operated by a non-technical person with appropriate training in connection with use of the device. Its software will enable the user to capture all data required to comply with the clinical laboratory improvement. The company was founded in July 1996 and is headquartered in Culver City, CA. | 5 years |
| Hugh O’Neill | M | 69 | 5 years | |
| Richard A. Doyle | M | 56 | 10 years | |
| K. Louise McLaren | F | - | - | |
| Kevin P. Dougherty | M | - | 25 years | |
| Mark Carol | M | - |
MagneVu Corp.
 MagneVu Corp. Electronic Equipment/InstrumentsElectronic Technology MagneVu Corp. develops, manufactures, and markets magnetic resonance imaging (MRI) devices. The firm's services include site planning, staff training, MRI protocol optimization, and RF shielding. It has locations in Alabama, California, Colorado, Georgia, Texas, Utah, and Illinois. The company was founded in 1991 and is headquartered in Carlsbad, CA. | - |
| Eric Granat | M | - | 2 years | |
| Robert M. Astley | M | 79 | 2 years | |
| Dennis E. Rieger | M | 78 |
Careside, Inc.
Careside, Inc. Medical SpecialtiesHealth Technology Careside, Inc. develops and sells a proprietary blood testing systems. The Careside system consists of the Careside Analyzer and disposable test cartridges, the H-2000 and Careside connect. The Careside Analyzer is easy to use and can be operated by a non-technical person with appropriate training in connection with use of the device. Its software will enable the user to capture all data required to comply with the clinical laboratory improvement. The company was founded in July 1996 and is headquartered in Culver City, CA. | - |
| Les Z. Ferenczi | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 5 years |
| Sandra P. Twyon | F | 85 |
Careside, Inc.
Careside, Inc. Medical SpecialtiesHealth Technology Careside, Inc. develops and sells a proprietary blood testing systems. The Careside system consists of the Careside Analyzer and disposable test cartridges, the H-2000 and Careside connect. The Careside Analyzer is easy to use and can be operated by a non-technical person with appropriate training in connection with use of the device. Its software will enable the user to capture all data required to comply with the clinical laboratory improvement. The company was founded in July 1996 and is headquartered in Culver City, CA. | - |
| George W. Carmany | M | 84 | 6 years | |
| Rick McKenney | M | 55 | 3 years | |
| Kenneth Asarch | M | 66 |
Careside, Inc.
Careside, Inc. Medical SpecialtiesHealth Technology Careside, Inc. develops and sells a proprietary blood testing systems. The Careside system consists of the Careside Analyzer and disposable test cartridges, the H-2000 and Careside connect. The Careside Analyzer is easy to use and can be operated by a non-technical person with appropriate training in connection with use of the device. Its software will enable the user to capture all data required to comply with the clinical laboratory improvement. The company was founded in July 1996 and is headquartered in Culver City, CA. | - |
| David Crais | M | 60 |
Careside, Inc.
Careside, Inc. Medical SpecialtiesHealth Technology Careside, Inc. develops and sells a proprietary blood testing systems. The Careside system consists of the Careside Analyzer and disposable test cartridges, the H-2000 and Careside connect. The Careside Analyzer is easy to use and can be operated by a non-technical person with appropriate training in connection with use of the device. Its software will enable the user to capture all data required to comply with the clinical laboratory improvement. The company was founded in July 1996 and is headquartered in Culver City, CA. | - |
| George M. Saiz | M | 70 |
Careside, Inc.
Careside, Inc. Medical SpecialtiesHealth Technology Careside, Inc. develops and sells a proprietary blood testing systems. The Careside system consists of the Careside Analyzer and disposable test cartridges, the H-2000 and Careside connect. The Careside Analyzer is easy to use and can be operated by a non-technical person with appropriate training in connection with use of the device. Its software will enable the user to capture all data required to comply with the clinical laboratory improvement. The company was founded in July 1996 and is headquartered in Culver City, CA. | - |
| Tom Tran | M | - | 1 years | |
| David Shin | M | - | 2 years | |
| Becky J. West | F | - | 4 years | |
| Mark Reddish | M | 69 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 7 years |
| Mark Krantz | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 15 years |
| Robert Salipante | M | 66 | - | |
| Jane Wolak | F | 63 | 6 years | |
| Michael Stramaglia | M | 64 | 10 years | |
| Eric Edward Baker | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
| Sheila Moriber Katz | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
| Germaine Gibara | F | 79 | 8 years | |
| Paul Willibrord Derksen | M | 72 | - | |
| Stephen K. Burley | M | 66 | - | |
| Robert Paul Reid | M | 90 | 5 years | |
| Robert D. Aubrey | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 17 years |
| Guy Ely | M | 71 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
| Ronald J. Helmhold | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 11 years |
| Marilyn Olson | F | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 18 years |
| Jane H. Tulloch | F | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
| Jim Huang | M | - | 2 years | |
| Diana Gonzalez | F | 46 | 4 years | |
| Gary Corsi | M | 69 | 1 years | |
| Michele van Leer | F | - | - | |
| James C. Baillie | M | 84 | - | |
| Thomas Anthony Bogart | M | - | 16 years | |
| David K. Stevenson | M | 81 | 11 years | |
| Guy Cipriani | M | 54 | 5 years | |
| Philip K. Polkinghorn | M | 66 | - | |
| Bill Wickson | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
| Bertin F. Nadeau | M | 82 | 12 years | |
| Madeleine Paquin | F | 61 | 4 years | |
| Jay Venkatesan | M | 52 | 1 years | |
| Danielle Morin | F | 68 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 66 | 72.53% |
| United States | 34 | 37.36% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- W. Vickery Stoughton
- Personal Network
